Genome-Wide Sequencing Identified Rare Genetic Variants for Childhood-Onset Monogenic Lupus

Objective. Genetics play an important role in systemic lupus erythematosus (SLE) pathogenesis. We calcu-lated the prevalence of rare variants in known monogenic lupus genes among children suspected of mono -genic lupus.Methods. We completed paired-end genome-wide sequencing (whole genome sequencing [WGS] or whole exome sequencing) in patients suspected of monogenic lupus, and focused on 36 monogenic lupus genes. We prioritized rare (minor allele frequency < 1%) exonic, nonsynonymous, and splice variants with predicted pathogenicity classified as deleterious variants (Combined Annotation Dependent Depletion [CADD], PolyPhen2, and Sorting Intolerant From Tolerant [SIFT] scores). Additional filtering restricted to pre-dicted damaging variants by considering reported zygosity. In those with WGS (n = 69), we examined copy number variants (CNVs) > 1 kb in size. We created additive non-HL A and HLA SLE genetic risk scores (GRSs) using common SLE-risk single-nucleotide polymorphisms. We tested the relationship between SLE GRSs and the number of rare variants with multivariate logistic models, adjusted for sex, ancestry, and age of diagnosis.Results. The cohort included 71 patients, 80% female, with a mean age at diagnosis of 8.9 (SD 3.2) years. We identified predicted damaging variants in 9 (13%) patients who were significantly younger at diagnosis compared to those without apredicted damaging variant (6.8 [SD 2.1] years vs 9.2 [SD 3.2] years, P = 0.01). We did not identify damaging CNVs. There was no significant association between non-HL A or HLA SLE GRSs and the odds of carrying & GE; 1 rare variant in multivariate analyses.Conclusion. In a cohort of patients with suspected monogenic lupus who underwent genome-wide sequencing, 13% carried rare predicted damaging variants for monogenic lupus. Additional studies are needed to validate our findings.

Automated summary

This study conducted genome-wide sequencing in children suspected of having monogenic lupus, and found that 13% of patients carried rare predicted damaging variants for monogenic lupus. Further studies are needed to validate these findings.